Signify Health downgraded by Baird with a new price target
$SGFY
Retail: Computer Software & Peripheral Equipment
Technology
Baird downgraded Signify Health from Outperform to Neutral and set a new price target of $24.00 from $30.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/31/2022 | $35.00 | Buy | BTIG Research |
| 7/29/2022 | $18.00 | Sector Perform | RBC Capital Mkts |
| 5/16/2022 | $19.00 → $16.00 | Neutral → Outperform | Robert W. Baird |
| 3/30/2022 | $36.00 | Buy | Guggenheim |
| 3/9/2022 | $27.00 → $18.00 | Market Perform | Cowen & Co. |
| 3/9/2022 | $20.00 → $21.00 | Neutral → Buy | UBS |
| 3/7/2022 | $34.00 → $27.00 | Overweight | Piper Sandler |
| 2/11/2022 | $20.00 | Buy | Goldman Sachs |
4 - Signify Health, Inc. (0001828182) (Issuer)
4 - Signify Health, Inc. (0001828182) (Issuer)
4 - Signify Health, Inc. (0001828182) (Issuer)
Advances long-term strategy by providing platform for growth in value-based care WOONSOCKET, R.I., DALLAS and NEW YORK, Sept. 5, 2022 /PRNewswire/ -- CVS Health® (NYSE:CVS) and Signify Health (NYSE:SGFY) ("Signify") have entered into a definitive agreement under which CVS Health will acquire Signify Health for $30.50 per share in cash, representing a total transaction value of approximately $8 billion. Signify Health is a leader in Health Risk Assessments, value-based care and provider enablement. With a network of more than 10,000 clinicians across all 50 states and a nationw
Financial Highlights Second Quarter 2022: Revenue of $246.2 million, an increase of 16% from second quarter 2021 GAAP net loss of $490.0 million, which includes a $519.9 million loss on impairment related to our decision to exit the Episodes of Care Services segment. Non-GAAP adjusted EBITDA1 of $62.6 million, an increase of 15% from second quarter 2021 2022 Guidance: Signify Health is providing guidance for full year 2022 as follows: Home & Community Services (HCS) segment revenue in the range of $800 million to $810 million; Revenue from the Caravan Health acquisition in the range of $45 million to $48 million; Adjusted EBITDA margin1 for HCS and Caravan Health of 29% to 3
Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform enabled by advanced analytics, technology and nationwide healthcare networks, announced that it will release its financial results for the second quarter 2022 after the market closes on Wednesday, August 3, 2022, and will hold a conference call at 8:30am ET on Thursday, August 4, 2022 to discuss the results. Pre-registration is required for participation in the conference call. Please follow the link below to pre-register. After registering, you will be provided with your access details via email. http://www.incommuk.com/customers/signifyhealthquartertwo2022 A webcast of the conference call will also be available
WOONSOCKET, R.I. and DALLAS and NEW YORK, March 27, 2023 /PRNewswire/ -- CVS Health® (NYSE:CVS) today announced it expects to complete its acquisition of Signify Health (NYSE:SGFY) on or around March 29, 2023, subject to the satisfaction or waiver of the remaining customary closing conditions set forth in the merger agreement. The companies entered into a definitive agreement in September 2022 under which CVS Health announced it would acquire Signify Health for $30.50 per share in cash for a total transaction value of approximately $8 billion. Upon completion of the acquisitio
DUBLIN, Ohio, March 6, 2023 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced its collaboration with Signify Health (NYSE:SGFY) to offer in-home clinical and medication management services through its Outcomes™ business. This collaboration will help reduce costs and eliminate gaps in care for more than 2.3 million members nationwide to support their treatment journey from prescription to pharmacy to home. Studies have shown that many members do not take their medications as prescribed. Bringing together Signify Health's1 mobile network of 11,000+ credentialed clinicia
Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced that Heather Dixon, CPA, has been appointed to the Company's Board of Directors as an independent board member, effective March 1, 2023. She fills the seat previously held by Steven Geringer and will serve as a member of the Audit Committee. Dixon currently serves as Chief Financial Officer of Everside Health, one of the nation's largest direct primary care providers. In this role, she provides financial oversight and strategic direction with a focus on growth and innovation within the direct primary care space. Prior to joining Everside, she was the Senior Vice President, Global Controller and Chie
SC 13G/A - Signify Health, Inc. (0001828182) (Subject)
SC 13G - Signify Health, Inc. (0001828182) (Subject)
SC 13G/A - Signify Health, Inc. (0001828182) (Subject)
A 30+ year industry veteran from Signify Health and Match.com, Shane joins to scale Virta's technology platform amid triple-digit year-over-year growth Today, diabetes reversal leader Virta Health announced the addition of Shane Henderson as Chief Technology Officer (CTO). With over three decades of experience at companies like Signify Health and Match.com, Shane joins to scale Virta's technology through continued triple-digit growth and surging demand for its innovative approach to treating metabolic diseases like type 2 diabetes, prediabetes, and obesity. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220510006160/en/As CTO, S
WALTHAM, Mass., Sept. 1, 2021 /PRNewswire/ -- GoodCell, a medically-actionable health technology service to proactively identify, track and address health risks, today announces it has appointed Chris Garcia as its new Chief Executive Officer and member of the Board of Directors, effective immediately. In his new role, Mr. Garcia will work to scale GoodCell's commercial strategy, while founder Trevor Perry will assume the title of President and remain as a director of the company. "The Board of Directors and I are excited to have Chris lead our organization into its next chapter of development," said Mr. Perry. "Chris' addition validates the value of what we have built at GoodCell to date a
Signify Health, Inc. (NYSE:SGFY), a leading value-based healthcare platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced the appointment of Arnold Goldberg as an independent member of its board of directors, serving on the audit committee. Most recently serving as Senior Vice President, Chief Product Architect and Senior Technologist at PayPal, Mr. Goldberg brings deep knowledge of platform architecture and product strategy to Signify Health, as well as valuable experience leading and scaling teams of technologists for some of the biggest and most groundbreaking technology companies of the past two decades. This press release fea
15-12G - Signify Health, Inc. (0001828182) (Filer)
25-NSE - Signify Health, Inc. (0001828182) (Subject)
S-8 POS - Signify Health, Inc. (0001828182) (Filer)
On CNBC’s "Halftime Report Final Trades," Stephen Weiss of Short Hills Capital Partners named UnitedHealth Group Incorporated (NYSE:UNH) as his final trade. Raymond James recently upgraded UnitedHealth Group from Outperform to Strong Buy and raised the price target from $615 to $630. Joshua Brown of Ritholtz Wealth Management said there's a "breakout in progress" on Oracle Corporation (NYSE:ORCL). Oracle announced plans to open a second cloud region in Singapore. Don’t forget to check out our premarket coverage here Jim Lebenthal of Cerity Partners picked CVS Health Corporation (NYSE:CVS). CVS Health said it expects to close on the acquisition of Signify Health Inc (NYSE:SGFY)
Signify Health Inc (NYSE:SGFY) shares are trading higher after CVS Health Corp (NYSE:CVS) said it expects to close on the acquisition of Signify on or around March 29. What Else? The companies entered into a definitive agreement in September 2022 under which CVS Health announced it would acquire Signify Health for $30.50 per share in cash for a total transaction value of approximately $8 billion. See Also: Why First Republic Bank Stock Is Popping Off Upon completion of the acquisition, Signify Health will continue to operate as a payor-agnostic business as part of CVS Health. According to data from Benzinga Pro, SGFY has a 52-week high of $29.88 and a 52-week low of $10.70.
BTIG Research initiated coverage of Signify Health with a rating of Buy and set a new price target of $35.00
RBC Capital Mkts initiated coverage of Signify Health with a rating of Sector Perform and set a new price target of $18.00
Robert W. Baird upgraded Signify Health from Neutral to Outperform and set a new price target of $16.00 from $19.00 previously